| Dr Alexandra Forsyth, PSYD | |
|
504 Sunset Dr, Cave Springs, AR 72718-8809 | |
| (479) 847-2042 | |
| Not Available |
| Full Name | Dr Alexandra Forsyth |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 504 Sunset Dr, Cave Springs, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386352102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 242246 (Kentucky) | Secondary |
| 103TC0700X | Psychologist - Clinical | 202296 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexandra Forsyth, PSYD 504 Sunset Dr, Cave Springs, AR 72718-8809 Ph: (479) 847-2042 | Dr Alexandra Forsyth, PSYD 504 Sunset Dr, Cave Springs, AR 72718-8809 Ph: (479) 847-2042 |
News Archive
The risk of depression appears to decrease for women with increasing consumption of caffeinated coffee, according to a report in the September 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Novartis Pharmaceuticals Corporation announced today that the company will work with Medicare-approved drug discount card sponsors to provide its products free of Novartis charges to low-income Medicare enrollees, after they have exhausted their $600 transitional assistance available from the government.
Getting plenty of vitamin E by eating foods like nuts and olive oil appears to cut in half people's risk of bladder cancer, the fourth leading cancer killer among men, a new study suggests.
BSD Medical Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of BSD's 510(k) Premarket Notification submission authorizes the commercial sale of the MTX-180 in the United States. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical oncology market.
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
› Verified 4 days ago